JP2013536206A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013536206A5 JP2013536206A5 JP2013525143A JP2013525143A JP2013536206A5 JP 2013536206 A5 JP2013536206 A5 JP 2013536206A5 JP 2013525143 A JP2013525143 A JP 2013525143A JP 2013525143 A JP2013525143 A JP 2013525143A JP 2013536206 A5 JP2013536206 A5 JP 2013536206A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- pharmaceutically acceptable
- phenyl
- dimethyl
- phenylsulfanyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37588510P | 2010-08-23 | 2010-08-23 | |
| US61/375,885 | 2010-08-23 | ||
| DKPA201000739 | 2010-08-23 | ||
| DKPA201000739 | 2010-08-23 | ||
| PCT/DK2011/050317 WO2012025123A1 (en) | 2010-08-23 | 2011-08-22 | Therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013536206A JP2013536206A (ja) | 2013-09-19 |
| JP2013536206A5 true JP2013536206A5 (enExample) | 2014-10-09 |
| JP5902169B2 JP5902169B2 (ja) | 2016-04-13 |
Family
ID=44532506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013525143A Active JP5902169B2 (ja) | 2010-08-23 | 2011-08-22 | １−［２−（２，４−ジメチル−フェニルスルファニル）フェニル］ピペラジンの治療的使用 |
Country Status (32)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA029060B1 (ru) | 2014-01-31 | 2018-02-28 | Эгиш Дьёдьсердьяр Зрт. | Способ получения солей вортиоксетина |
| CN104119298B (zh) * | 2014-08-13 | 2016-08-24 | 北京蓝贝望生物医药科技股份有限公司 | 氢溴酸沃赛汀或氢溴酸沃替西汀 |
| CN104119299B (zh) * | 2014-08-13 | 2016-08-17 | 北京蓝贝望生物医药科技股份有限公司 | 沃赛汀或沃替西汀的氢溴酸盐 |
| CN104610195B (zh) * | 2015-01-30 | 2017-06-27 | 上虞京新药业有限公司 | 沃替西汀的天冬氨酸盐或其水合物及其制备方法和用途 |
| JP2019524682A (ja) | 2016-07-01 | 2019-09-05 | ハー・ルンドベック・アクチエゼルスカベット | 抗うつ作用の速い発現のためのボルチオキセチン投与計画 |
| EP3870292A4 (en) | 2018-10-26 | 2022-11-09 | The Research Foundation for The State University of New York | COMBINATION OF SEROTONIN-SPECIFIC RESUPPUT INHIBITOR AND SEROTONIN 1A RECEPTOR PARTIAL AGONIST TO REDUCE L-DOPA-INDUCED DYSKINESIA |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8430581D0 (en) * | 1984-12-04 | 1985-01-09 | Ferrosan As | Treatment |
| ES2087463T3 (es) * | 1991-11-18 | 1996-07-16 | Lilly Industries Ltd | Benzo(b)tiofen-2-carboxamidas para el tratamiento de trastornos del sistema nervioso central. |
| US20080103179A1 (en) * | 2006-10-27 | 2008-05-01 | Tam Peter Y | Combination Therapy |
| WO2002029232A1 (en) | 2000-10-02 | 2002-04-11 | Rohr, Inc. | Apparatus, method and system for gas turbine engine noise reduction |
| UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| KR20090028712A (ko) * | 2006-06-16 | 2009-03-19 | 하. 룬트벡 아크티에 셀스카브 | 인지기능 장애의 치료를 위한, 세로토닌 재흡수, 5-ｈｔ3 및 5-ｈｔ1ａ 활성이 조합된 화합물로서의 1-[2-(2,4-디메틸페닐술파닐)-페닐]피페라진 |
| TW200848411A (en) | 2007-03-20 | 2008-12-16 | Lundbeck & Co As H | Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine |
| TW200932233A (en) * | 2007-11-13 | 2009-08-01 | Lundbeck & Co As H | Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity |
-
2011
- 2011-08-17 TW TW100129338A patent/TW201212918A/zh unknown
- 2011-08-19 AR ARP110103029A patent/AR082501A1/es not_active Application Discontinuation
- 2011-08-22 ES ES11749331T patent/ES2625142T5/es active Active
- 2011-08-22 HR HRP20170608TT patent/HRP20170608T4/hr unknown
- 2011-08-22 DK DK11749331.2T patent/DK2608789T4/da active
- 2011-08-22 JP JP2013525143A patent/JP5902169B2/ja active Active
- 2011-08-22 IL IL224371A patent/IL224371A/en active IP Right Grant
- 2011-08-22 RS RS20170404A patent/RS55851B2/sr unknown
- 2011-08-22 AU AU2011295465A patent/AU2011295465B8/en active Active
- 2011-08-22 SG SG2013007380A patent/SG187649A1/en unknown
- 2011-08-22 CA CA2807062A patent/CA2807062C/en active Active
- 2011-08-22 RU RU2013112890/15A patent/RU2564666C2/ru active
- 2011-08-22 SI SI201131177T patent/SI2608789T2/sl unknown
- 2011-08-22 CN CN2011800406861A patent/CN103068389A/zh active Pending
- 2011-08-22 PL PL11749331.2T patent/PL2608789T5/pl unknown
- 2011-08-22 PT PT117493312T patent/PT2608789T/pt unknown
- 2011-08-22 BR BR112013002194A patent/BR112013002194A2/pt not_active Application Discontinuation
- 2011-08-22 BR BR122020025600A patent/BR122020025600A2/pt not_active Application Discontinuation
- 2011-08-22 HU HUE11749331A patent/HUE034155T2/en unknown
- 2011-08-22 FI FIEP11749331.2T patent/FI2608789T4/fi active
- 2011-08-22 WO PCT/DK2011/050317 patent/WO2012025123A1/en not_active Ceased
- 2011-08-22 LT LTEP11749331.2T patent/LT2608789T/lt unknown
- 2011-08-22 US US13/812,073 patent/US20130184291A1/en not_active Abandoned
- 2011-08-22 KR KR1020137004481A patent/KR101816953B1/ko active Active
- 2011-08-22 EP EP11749331.2A patent/EP2608789B2/en active Active
- 2011-08-22 SM SM20170239T patent/SMT201700239T1/it unknown
- 2011-08-22 ME MEP-2017-94A patent/ME02674B/me unknown
- 2011-08-22 MX MX2013001570A patent/MX349724B/es active IP Right Grant
- 2011-08-22 AP AP2013006768A patent/AP3583A/xx active
-
2013
- 2013-02-20 CL CL2013000492A patent/CL2013000492A1/es unknown
- 2013-02-21 CO CO13035030A patent/CO6680652A2/es unknown
- 2013-02-22 ZA ZA2013/01385A patent/ZA201301385B/en unknown
-
2017
- 2017-05-10 CY CY20171100501T patent/CY1118886T1/el unknown
-
2018
- 2018-09-07 US US16/124,497 patent/US20190000836A1/en not_active Abandoned
-
2020
- 2020-05-18 US US16/877,108 patent/US20210085674A1/en not_active Abandoned
-
2022
- 2022-01-07 US US17/570,998 patent/US20220370439A1/en not_active Abandoned
-
2023
- 2023-10-10 US US18/483,780 patent/US20240293397A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bahr et al. | Intranasal esketamine (SpravatoTM) for use in treatment-resistant depression in conjunction with an oral antidepressant | |
| TWI776407B (zh) | 激動劑形成之調配物及使用其之方法 | |
| JP4938905B2 (ja) | 選択的ｓ１ｐ１レセプターアゴニストの投与法 | |
| JP2024074963A (ja) | トラジピタントによる治療方法 | |
| JP2014517050A5 (enExample) | ||
| JP2017528507A5 (enExample) | ||
| JP2013536206A5 (enExample) | ||
| JP2024016113A (ja) | ハンチントン病及びその症状を治療するためのプリドピジン及びその類似体を含む組成物 | |
| Papakostas et al. | A 12-week, randomized, double-blind, placebo-controlled, sequential parallel comparison trial of ziprasidone as monotherapy for major depressive disorder | |
| CA3083341C (en) | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions | |
| JP2021504384A5 (enExample) | ||
| CN105764510A (zh) | H3受体拮抗剂与胆碱酶抑制剂组合用于阿尔茨海默氏病治疗中的用途 | |
| RU2013112890A (ru) | Терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина | |
| JP2019507786A5 (enExample) | ||
| Grunberg et al. | Chemotherapy-induced nausea and vomiting: contemporary approaches to optimal management: Proceedings from a symposium at the 2008 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting | |
| US9724340B2 (en) | Antitussive compositions and methods | |
| JP2018203774A (ja) | 精神障害の治療における使用のためのイロペリドン代謝物 | |
| CN110573148A (zh) | 特发性肺纤维化的治疗 | |
| JP2012502105A5 (enExample) | ||
| JP2007519646A (ja) | 体重の持続的低減のための化合物 | |
| JP2021503448A5 (enExample) | ||
| JP2020535139A (ja) | シポニモドの投与レジメン | |
| TWI864376B (zh) | 焦慮症處置用組成物及處置方法 | |
| JP2023501186A (ja) | グルタミン酸２ｂ受容体拮抗薬及びシグマ受容体作動薬の鎮咳薬としての使用 | |
| JP7818826B2 (ja) | 好酸球性喘息の処置のためのｍａｓｉｔｉｎｉｂの使用 |